| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/11/2011 | WO2011096377A1 Pyrrole compound |
| 08/11/2011 | WO2011096374A1 Novel iodobenzyl-bleomycin compound |
| 08/11/2011 | WO2011096211A1 Whsc1 and whsc1l1 for target genes of cancer therapy and diagnosis |
| 08/11/2011 | WO2011096210A1 Prmt1 and prmt6 for target genes of cancer therapy and diagnosis |
| 08/11/2011 | WO2011095835A1 Highly pure imatinib or a pharmaceutically acceptable salt thereof |
| 08/11/2011 | WO2011095807A1 Combinations of mek and hh inhibitors |
| 08/11/2011 | WO2011095498A1 A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma |
| 08/11/2011 | WO2011095495A1 Compositions and methods for inhibiting expression of ikk2 genes |
| 08/11/2011 | WO2011095095A1 Medicinal composition comprising alcohol-soluble and water-insoluble licorice extract, pharmaceutical preparation, pharmaceutical application, therapeutic method, and preparative method thereof |
| 08/11/2011 | WO2011095068A1 Pharmaceutically acceptable salts of pyrrolo-nitrogenous heterocyclic derivatives, preparation method and medical use thereof |
| 08/11/2011 | WO2011095059A1 Polymorphs of dasatinib, preparation methods and pharmaceutical compositions thereof |
| 08/11/2011 | WO2011095053A1 Quinazoline derivatives, preparation methods and uses thereof |
| 08/11/2011 | WO2011095045A1 Pyridinone amide derivatives, preparation methods and medical uses thereof |
| 08/11/2011 | WO2011095027A1 Pyridyl cyanoguanidine derivatives |
| 08/11/2011 | WO2011094806A1 Diagnostic and prognostic assay for breast cancer |
| 08/11/2011 | WO2011073629A3 Cancer diagnosis and treatment |
| 08/11/2011 | WO2011072627A3 Dendritic high-molecular-weight polymer drug carriers and their conjugates with drugs especially for treatment of solid tumours |
| 08/11/2011 | WO2011070358A3 Systemic administration of an agent that permeabilises tumour vasculature |
| 08/11/2011 | WO2011066352A8 An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase |
| 08/11/2011 | WO2011055142A3 1,4-quinones and their sulfur analogues useful as ligands of n-acetyltransferases |
| 08/11/2011 | WO2011049659A3 Novel use and method of rapamycin to treat toxic shock |
| 08/11/2011 | WO2011043809A9 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 08/11/2011 | WO2011041462A3 Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| 08/11/2011 | WO2011038159A3 Dr5 ligand drug conjugates |
| 08/11/2011 | WO2011020056A3 Methods of treating cancer using galanin retargeted endpeptidases |
| 08/11/2011 | WO2010092260A8 Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate and polymorphs thereof |
| 08/11/2011 | US20110197292 Delivery method |
| 08/11/2011 | US20110196474 Magnetically sensitive drug carriers for treatment or targeted delivery |
| 08/11/2011 | US20110196128 Murine zcytor17 ligand polynucleotides |
| 08/11/2011 | US20110196043 Methods and compositions for administration of trpv1 agonists |
| 08/11/2011 | US20110196030 Tocotrienol esters |
| 08/11/2011 | US20110196029 Composition for treating influenza a (h1n1) virus and a preparation method therefor |
| 08/11/2011 | US20110196028 PCK ACTIVATION AS A MEANS FOR ENHANCING sAPPa SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| 08/11/2011 | US20110196025 Polymorphs of N-Malonyl-Bis(N'-Methyl-N'-Thiobenzoylhydrazide) |
| 08/11/2011 | US20110196019 Treatment of Cancer by Inhibition of IGFBPs and Clusterin |
| 08/11/2011 | US20110196017 Micro-rna that promotes vascular integrity and uses thereof |
| 08/11/2011 | US20110196010 Crystalline chemotherapeutic |
| 08/11/2011 | US20110196009 INHIBITORS OF Akt ACTIVITY |
| 08/11/2011 | US20110196005 Antagonists of lysophosphatidic acid receptors |
| 08/11/2011 | US20110196004 Crystalline forms of (r) -5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz [z] ylidene] -2-( [z]-propylimino) -3-0-tolyl-thiazolidin-4-one |
| 08/11/2011 | US20110195995 Methods of Optimizing Treatment of Estrogen-Receptor Positive Breast Cancers |
| 08/11/2011 | US20110195990 Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 08/11/2011 | US20110195987 Treatment with cholinergic agonists |
| 08/11/2011 | US20110195982 Predictive marker for egfr inhibitor treatment |
| 08/11/2011 | US20110195975 Materials and methods for suppressing and/or treating neurofibroma and related tumors |
| 08/11/2011 | US20110195967 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 08/11/2011 | US20110195966 Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor |
| 08/11/2011 | US20110195965 Tetrahydro- and dihydroquinazolinones |
| 08/11/2011 | US20110195964 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents |
| 08/11/2011 | US20110195960 Inhibitors of c-fms kinase |
| 08/11/2011 | US20110195959 Compositions And Methods Relating To Novel Compounds And Targets Thereof |
| 08/11/2011 | US20110195958 Activators of human pyruvate kinase |
| 08/11/2011 | US20110195956 Heterocyclic Kinase Inhibitors |
| 08/11/2011 | US20110195948 Substituted Pyrazolo[1,5-a]Pyrimidine Compounds as TRK Kinase Inhibitors |
| 08/11/2011 | US20110195947 Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same |
| 08/11/2011 | US20110195939 Antitumor properties of no modified protease inhibitors |
| 08/11/2011 | US20110195924 Methods of Inhibiting the Interaction Between S100P and the Receptor for Advanced Glycation End-Products |
| 08/11/2011 | US20110195923 Methods for Predicting the Response to Anti-Cancer Treatment with an Agonist of TLR7 or an Agonist of TLR8 |
| 08/11/2011 | US20110195918 Method for producing pectin hydrolysis products |
| 08/11/2011 | US20110195915 Method of inhibiting prostate cancer cell proliferation |
| 08/11/2011 | US20110195914 Macrocyclic antiproliferation agents and methods of treatment |
| 08/11/2011 | US20110195911 Synthetic analogs of the juxtamembrane domain of igf1r and uses thereof |
| 08/11/2011 | US20110195910 Use of tocotrienol composition for the prevention of cancer |
| 08/11/2011 | US20110195907 Amino acid and peptide conjugates of amiloride and methods of use thereof |
| 08/11/2011 | US20110195902 Fusion Protein Composed of Matrix Metalloproteinase-2 Inhibitor Peptide Derived From Amyloid-B Precursor Protein and Tissue Inhibitor of Metalloproteinase-2 |
| 08/11/2011 | US20110195901 Artery- and vein-specific proteins and uses therefor |
| 08/11/2011 | US20110195844 Process for solubilizing hydrophobic active ingredients in aqueous medium |
| 08/11/2011 | US20110195133 Dermcidin-derived peptides for lung cancer diagnostics |
| 08/11/2011 | US20110195129 Water having anticancer activity and method for making the same |
| 08/11/2011 | US20110195123 Methods, compositions and systems for local delivery of drugs |
| 08/11/2011 | US20110195111 Aqueous compositions and methods |
| 08/11/2011 | US20110195110 Urea compounds useful in the treatment of cancer |
| 08/11/2011 | US20110195094 Triazole compounds that modulate hsp90 activity |
| 08/11/2011 | US20110195093 Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers |
| 08/11/2011 | US20110195090 Method of making a vaccine |
| 08/11/2011 | US20110195081 Foxm1 peptide and medicinal agent comprising the same |
| 08/11/2011 | US20110195077 Methods and compositions using fgf23 fusion ppolypeptides |
| 08/11/2011 | US20110195076 Therapeutic agent |
| 08/11/2011 | US20110195074 Ephrin Type-A Receptor 7 Protein |
| 08/11/2011 | US20110195073 Compositions and methods for stimulating an immune response |
| 08/11/2011 | US20110195071 Therapy-enhancing glucan |
| 08/11/2011 | US20110195070 Detection of granulosa-cell tumors |
| 08/11/2011 | US20110195068 Pd-1 antagonists and methods of use thereof |
| 08/11/2011 | US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS |
| 08/11/2011 | US20110195066 Quinoline inhibitors of tyrosine kinase |
| 08/11/2011 | US20110195065 Compositions and Methods for Diagnosing and Treating Cancer |
| 08/11/2011 | US20110195064 Survival predictor for diffuse large b cell lymphoma |
| 08/11/2011 | US20110195063 Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor |
| 08/11/2011 | US20110195053 Treatment of Non-Neuronal Cancer using HSV-1 Variants |
| 08/11/2011 | US20110195050 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 08/11/2011 | US20110195047 Oncostatin m as promoter of immunostimulatory activity of human epithelial cells |
| 08/11/2011 | US20110195046 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 08/11/2011 | US20110195045 Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors |
| 08/11/2011 | US20110195043 Dimeric Smac Mimetics |
| 08/11/2011 | US20110195030 Nanoparticle compositions comprising liquid oil cores |
| 08/11/2011 | US20110195027 Cd9-specific human antibodies |
| 08/11/2011 | US20110195026 Protein |
| 08/11/2011 | US20110195023 Internalizing Anti-CD74 Antibodies and Methods of Use |
| 08/11/2011 | US20110195022 Cd20 antibodies and uses thereof |
| 08/11/2011 | US20110195021 Cd20 antibodies and uses thereof |